Interleukin 6 (IL-6) antibody and antigen (Recombinant protein)
Diagnostic Interleukin 6 (IL-6) antibodies (anti-Interleukin 6, anti-IL-6) and antigens (recombinant Interleukin 6 (IL-6) protein) for Inflammation/autoimmune/inflammatory disease IL-6 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-IL-6-Ag01 | Recombinant human IL6/IL-6/IFNB2 Protein | 3090 |
GMP-h-IL-6-Ab01 | Anti-human IL6/IL-6/IFNB2 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-IL-6-Ab02 | Anti-human IL6/IL-6/IFNB2 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-IL-6-Ab03 | Anti-human IL6/IL-6/IFNB2 human monoclonal antibody (mAb) | 1953 |
GMP-h-IL-6-Ab04 | Anti-human IL6/IL-6/IFNB2 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-IL-6-Ag01 |
Product Name | Recombinant human IL6/IL-6/IFNB2 Protein |
Target/Biomarker | Interleukin 6 (IL-6) |
Alias of Target/Biomarker | BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2, IFNB2, IL-6 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Interleukin 6 (IL-6) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IL-6 level test of Inflammation/autoimmune/inflammatory disease (systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human IL6/IL-6/IFNB2 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-IL-6-Ab01, GMP-h-IL-6-Ab02 |
Product Name | Anti-human IL6/IL-6/IFNB2 mouse monoclonal antibody (mAb) |
Target/Biomarker | Interleukin 6 (IL-6) |
Alias of Target/Biomarker | BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2, IFNB2, IL-6 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Interleukin 6 (IL-6) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IL-6 level test of Inflammation/autoimmune/inflammatory disease (systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human IL6/IL-6/IFNB2 mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-IL-6-Ab03, GMP-h-IL-6-Ab04 |
Product Name | Anti-human IL6/IL-6/IFNB2 human monoclonal antibody (mAb) |
Target/Biomarker | Interleukin 6 (IL-6) |
Alias of Target/Biomarker | BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2, IFNB2, IL-6 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Interleukin 6 (IL-6) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IL-6 level test of Inflammation/autoimmune/inflammatory disease (systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human IL6/IL-6/IFNB2 human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
GeneMedi's IL-6 (Interleukin 6) Antibody Pair Validation In Sandwich ELISA
Figure. GeneMedi's IL-6 antibody pair validation with IL-6 antigen (IL-6-Ag01) in sandwich ELISA.
Abbreviation | Description |
IL-6-Ab01 | GMP-h-IL-6-Ab01 |
IL-6-Ab02 | GMP-h-IL-6-Ab02 |
IL6-Ab03 | GMP-h-IL6-Ab03 |
IL-6-Ag01 | GMP-h-IL-6-Ag01 |
Click to get more Data / Case study about the product.
Target/Biomarker information
Interleukin 6 (IL-6), promptly and transiently produced in response to infections and tissue injuries, contributes to host defense through the stimulation of acute phase responses, hematopoiesis, and immune reactions. Levels of circulating IL-6 are elevated in several inflammatory diseases including rheumatoid arthritis, systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease. IL‐6 has been used as an inflammatory marker as independently associated with the risk of major disease.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments